Pharmaceutical intermediates are chemical products used in the process of pharmaceutical synthesis, serving as raw materials for the production of APIs. Pharmaceutical intermediates are a crucial component in the chain of pharmaceutical chemical materials, bridging the gap between raw materials and finished pharmaceutical products.MORE
Based on the long-term cooperative relationships with globally renowned enterprises, the company has accumulated expertise in synthetic purification, metal ion analysis and removal capabilities, pilot-scale production advantages, and enjoys a strong reputation in the Japanese market.MORE
Xi'an Manareco New Materials Co., Ltd. was established in 1999. It is jointly owned by investment institutions such as Zhuoshi Partnership and Gainful Investment, as well as senior management personnel within the company. The company is a high-tech enterprise focused on the research, development, production, and sales of specialized organic new materials. Its main products include monolithic liquid crystals, OLED materials, and innovative pharmaceutical intermediates.
R&D and testing personnel
Number of production lines
The report estimates the global and Chinese CDMO market size. From a global perspective, the CDMO industry is in a continuous trend of large-scale development, maintaining a high market prosperity. From 2017 to 2022, the global CDMO market size increased from$39. 4 billion to$63. 2 billion, with a compound annual growth rate of 12. 5%. It is expected to reach$124. 3 billion in 2025 and$231 billion in 2030.
On April 20, 2022, the 34th Meeting of the Standing Committee of the 13th National People's Congress passed the Futures and Derivatives Law of the China, which will come into force on August 1, 2022. Investors who engage in futures trading should choose suitable investment varieties through legitimate futures trading institutions after conducting necessary risk assessments. When investors download futures trading software or browse the webpage information of legitimate institutions, they should log in to the official website to prevent losses such as information leakage, password theft, and being deceived by phishing websites or other illegal websites. According to the regulations of the China Securities Regulatory Commission
Throughout 2016, the 12386 investor hotline received nearly 400 complaints from investors about securities and futures trading institutions exaggerating investment product returns and misleading investors through false advertising. By browsing the official websites of various business institutions, we also found that business institutions generally pay attention to promoting the product's return rate when promoting products. On their official websites, they usually focus on displaying the name, term, return rate, and purchase starting point of the sold product, and less on indicating the corresponding risk level of the product and proposing appropriate matching plans based on investors'risk preferences.